Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABBV

Abbvie Inc

Mar 25 • 03:05PM ET

199.53

Dollar change -9.64
Percentage change -4.61	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: JNJ PFE MRK LLY BMY GILD AMGN REGN VRTX BIIB

| Held by: VTI VOO SPY IVV VTV SCHD XLV VIG VYM VHT

Scroll to Statements

Index	S&P 500	P/E	83.43	EPS (ttm)	2.39	Insider Own	0.11%	Shs Outstand	1.77B	Perf Week	-6.70%
Market Cap	352.24B	Forward P/E	14.24	EPS next Y	14.01	Insider Trans	-10.25%	Shs Float	1.76B	Perf Month	-2.23%
Income	4.24B	PEG	5.44	EPS next Q	2.51	Inst Own	73.56%	Short Float	1.05%	Perf Quarter	16.33%
Sales	56.33B	P/S	6.25	EPS this Y	21.53%	Inst Trans	0.86%	Short Ratio	3.05	Perf Half Y	3.13%
Book/sh	1.88	P/B	105.93	EPS next Y	13.92%	ROA	3.14%	Short Interest	18.51M	Perf Year	12.41%
Cash/sh	3.15	P/C	63.41	EPS next 5Y	15.35%	ROE	61.94%	52W Range	153.58 - 218.66	Perf YTD	12.28%
Dividend Est.	6.50 (3.26%)	P/FCF	19.75	EPS past 5Y	-14.67%	ROI	6.58%	52W High	-8.75%	Beta	0.55
Dividend TTM	6.29 (3.15%)	Quick Ratio	0.55	Sales past 5Y	12.19%	Gross Margin	70.12%	52W Low	29.92%	ATR (14)	4.72
Dividend Ex-Date	Apr 15, 2025	Current Ratio	0.66	EPS Y/Y TTM	-12.14%	Oper. Margin	21.57%	RSI (14)	39.48	Volatility	1.58% 2.19%
Employees	55000	Debt/Eq	20.40	Sales Y/Y TTM	3.71%	Profit Margin	7.52%	Recom	1.71	Target Price	217.22
Option/Short	Yes / Yes	LT Debt/Eq	18.36	EPS Q/Q	-103.95%	Payout	263.15%	Rel Volume	0.98	Prev Close	209.17
Sales Surprise	1.82%	EPS Surprise	2.12%	Sales Q/Q	5.60%	Earnings	Jan 31 BMO	Avg Volume	6.06M	Price	199.53
SMA20	-5.21%	SMA50	2.12%	SMA200	7.07%	Trades		Volume	5,131,306	Change	-4.61%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$191
Dec-05-24	Downgrade	Daiwa Securities	Outperform → Neutral	$180
Nov-22-24	Upgrade	Leerink Partners	Market Perform → Outperform	$206
Nov-15-24	Initiated	Wolfe Research	Outperform	$205
Nov-04-24	Upgrade	Argus	Hold → Buy
Oct-17-24	Initiated	Bernstein	Mkt Perform	$203
Jun-05-24	Upgrade	HSBC Securities	Hold → Buy	$185
May-17-24	Initiated	Cantor Fitzgerald	Overweight	$200
Jan-29-24	Upgrade	William Blair	Mkt Perform → Outperform
Dec-18-23	Downgrade	HSBC Securities	Buy → Hold
Dec-11-23	Upgrade	Goldman	Neutral → Buy
Nov-09-23	Initiated	Deutsche Bank	Hold	$150
Oct-30-23	Upgrade	Barclays	Equal Weight → Overweight	$160 → $170
Oct-20-23	Resumed	UBS	Neutral	$157 → $150
Sep-29-23	Initiated	Raymond James	Outperform	$177
Jul-25-23	Initiated	William Blair	Mkt Perform
Jul-14-23	Initiated	HSBC Securities	Buy	$167
Apr-05-23	Downgrade	Argus	Buy → Hold
Mar-01-23	Initiated	Guggenheim	Buy	$172
Feb-22-23	Downgrade	Wolfe Research	Outperform → Peer Perform

Show Previous Ratings

Today 01:13PM	These Dividend Aristocrats Stocks Can Protect You From the Market Selloff (Barrons.com)
09:01AM	3 Healthcare Stocks in the Doghouse (StockStory)
06:47AM	5 Large Drug Stocks to Watch as Industry Recovers (Zacks)
06:20AM	Is SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now? (Zacks)
Mar-24-25 05:45PM	AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why (Zacks)
04:02AM	Loading…
04:02AM	Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025 (PR Newswire)
Mar-23-25 01:55PM	Is AbbVie Inc. (ABBV) The Best Healthcare Dividend Stock to Invest in? (InsiderMonkey)
10:00AM	SCHD: Good Times Aren't Great (Rating Downgrade) (SeekingAlpha)
07:19AM	AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market (MarketBeat)
07:18AM	Wall Street Week Ahead (SeekingAlpha)
Mar-21-25 12:59PM	2025 Dividend Kings: Strong Run Continues (SeekingAlpha)
11:31AM	Unlocking Intrinsic Value: Analysis of AbbVie Inc (GuruFocus.com)
08:28AM	J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease (Zacks)
07:21AM	Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy (SeekingAlpha)
Mar-20-25 11:20AM	Defensive Stocks For Unpredictable Trump Policy (SeekingAlpha)
09:40AM	Loading…
09:40AM	My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys (SeekingAlpha)
09:31AM	Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends (Motley Fool)
09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
Mar-19-25 09:21PM	BlackRock Global Dividend Fund Q4 2024 Commentary (SeekingAlpha)
07:30AM	3 Dividend Stocks to Buy for Reliable Passive Income (Fool)
Mar-18-25 05:45PM	AbbVie (ABBV) Stock Moves -0.29%: What You Should Know (Zacks)
09:20AM	AbbVie upgraded to Buy at Erste Group on Friday (TipRanks)
Mar-17-25 06:26AM	AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer (Clinical Trials Arena)
Mar-16-25 06:19PM	1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction (Motley Fool)
Mar-15-25 08:00AM	ELAHERE (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients (PR Newswire)
Mar-14-25 09:39AM	Q4 2024 Regenxbio Inc Earnings Call (Thomson Reuters StreetEvents)
05:51AM	3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now (Motley Fool)
05:30AM	Big Pharma Walked Away From Mental Health. Why Some Are Coming Back. (The Wall Street Journal)
Mar-13-25 09:00AM	AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know (Zacks)
02:37PM	Loading…
Mar-12-25 02:37PM	Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds (Insider Monkey)
02:26PM	Calls of the Day: United Airlines, Delta, IBM, Abbvie, Uber (CNBC TV)
12:02PM	Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo stock slides 4% (Yahoo Finance)
12:02PM	Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4% (Yahoo Finance)
07:10AM	Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever. (Motley Fool)
Mar-11-25 05:45PM	Why AbbVie (ABBV) Dipped More Than Broader Market Today (Zacks)
05:03AM	Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks (StockStory)
04:37AM	AbbVie Inc. (ABBV): A Magnificent Dividend Growth Stock to Invest In (Insider Monkey)
Mar-10-25 04:30PM	Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out (Investor's Business Daily)
03:40PM	Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now? (Insider Monkey)
07:57AM	This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy? (Motley Fool)
Mar-07-25 08:46PM	AbbVie Inc. (ABBV): Among The Stocks With At Least $10 Million In Insider Sales Recently (Insider Monkey)
05:30AM	3 Cheap Stocks to Buy With Your Tax Refund Check (Motley Fool)
05:03AM	2 Dividend Stocks to Buy for a Lifetime of Passive Income (Motley Fool)
Mar-05-25 03:39PM	Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out (Barrons.com)
01:31PM	5 Big Biopharmaceutical Stocks That Are Finding Favor (Barrons.com)
Mar-04-25 08:19AM	Ariel Global Fund Added AbbVie (ABBV) on Dip (Insider Monkey)
08:00AM	SKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease (PR Newswire)
08:00AM	AbbVie to Present at the Leerink Partners Global Healthcare Conference (PR Newswire)
06:02AM	Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value (GuruFocus.com)
04:03AM	Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4 (StockStory)
03:52AM	AbbVie Inc. (ABBV): Among the Best S&P 500 Dividend Stocks to Buy Now (Insider Monkey)
Mar-03-25 05:46PM	Asian Stocks to Decline as Tariffs Spark US Rout: Markets Wrap (Bloomberg)
05:45PM	AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts (Zacks)
04:20PM	AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion. (Investor's Business Daily)
03:49PM	AbbVie enters obesity treatment via Gubra licensing agreement (Yahoo Finance Video)
01:46PM	AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal (Investopedia)
01:45PM	Final Trades: Taiwan Semi, Abbvie, Tradeweb Markets and the IYH (CNBC TV)
01:15PM	AbbVie, Reddit, Allegro MicroSystems: Market Minute (Yahoo Finance Video)
07:52AM	AbbVie enters obesity space with $2.3bn Gubra deal (Pharmaceutical Technology)
06:49AM	AbbVie gets into obesity with $350M deal for once-weekly shot (BioPharma Dive)
01:11AM	AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity (PR Newswire)
Mar-02-25 12:24PM	Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Mar-01-25 03:30PM	AbbVie Inc. (ABBV): Among the Best Psychedelic Stocks to Buy in 2025 (Insider Monkey)
Feb-28-25 02:32PM	AbbVie's Next Big Moneymaker? This Drug Just Took a Huge Step Toward Approval (GuruFocus.com)
10:39AM	CHMP recommends AbbVies Rinvoq be approved for adult GCA (Pharmaceutical Technology)
07:00AM	Drug Stocks Are the New Safe Bet in a Shaky Market (The Wall Street Journal)
04:07AM	3 Reasons ABBV is Risky and 1 Stock to Buy Instead (StockStory)
02:00AM	AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ) for the Treatment of Adults with Giant Cell Arteritis (PR Newswire)
Feb-27-25 10:15PM	AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript (Motley Fool)
05:47AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever (Motley Fool)
Feb-26-25 09:00AM	AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:00AM	AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference (PR Newswire)
Feb-25-25 09:49AM	The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value (GuruFocus.com)
09:41AM	Is AbbVie Inc. (ABBV) the Best DRIP Stock to Own Now? (Insider Monkey)
05:56AM	Sionna Therapeutics IPO: A strategic shift in the cystic fibrosis market (Pharmaceutical Technology)
Feb-24-25 09:14AM	AbbVie Inc. (ABBV): Among S&P 500 Dividend Aristocrats List (Insider Monkey)
Feb-23-25 07:00AM	2 High-Yield Dividend ETFs to Buy to Generate Passive Income (Motley Fool)
Feb-20-25 05:30AM	2 Magnificent Dividend Growth Stocks to Load Up On Right Now (Motley Fool)
Feb-19-25 08:53AM	Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent (Yahoo Finance)
02:40AM	The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value (GuruFocus.com)
Feb-17-25 02:48AM	Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now (Insider Monkey)
Feb-15-25 04:55AM	Is AbbVie Stock a Buy Now? (Motley Fool)
Feb-14-25 07:40AM	AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors (PR Newswire)
Feb-13-25 11:57AM	AbbVie Declares Quarterly Dividend (PR Newswire)
10:48AM	AbbVie Inc. (ABBV): Among Lee Munder Capital Groups Top Stock Picks (Insider Monkey)
10:33AM	Neumora shakes up its C-suite; Biogen cuts early-stage pipeline (BioPharma Dive)
04:17AM	AbbVie and Xilio to collaborate on antibody-based immunotherapies (Pharmaceutical Technology)
Feb-12-25 10:44AM	Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday? (Benzinga)
08:30AM	Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training (PR Newswire)
07:30AM	AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies (PR Newswire)
Feb-11-25 03:20PM	Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns (Benzinga)
08:01AM	Biogen (BIIB) Reports Earnings Tomorrow: What To Expect (StockStory)
06:02AM	Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc (GuruFocus.com)
Feb-10-25 08:04AM	Gilead Sciences (GILD) Q4 Earnings: What To Expect (StockStory)
07:02AM	AbbVie, Pfizer gain FDA OK for novel antibiotic (BioPharma Dive)
04:37AM	FDA approves AbbVies Emblaveo for intra-abdominal infections (Pharmaceutical Technology)
Feb-09-25 02:30PM	3 Fabulous Dividend Stocks to Buy in February (Motley Fool)
08:04AM	Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For (StockStory)
08:02AM	Earnings To Watch: Incyte (INCY) Reports Q4 Results Tomorrow (StockStory)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Mar 14 '25	Sale	212.34	17,644	3,746,527	11,577	Mar 18 05:00 PM
Reents Scott T	Officer	Mar 14 '25	Proposed Sale	212.35	17,644	3,746,628		Mar 14 04:34 PM
GONZALEZ RICHARD A	Director	Feb 28 '25	Sale	205.11	92,460	18,964,471	395,097	Mar 04 05:00 PM
GONZALEZ RICHARD A	Director	Mar 03 '25	Sale	210.53	6,168	1,298,549	388,929	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Option Exercise	159.88	18,008	2,879,040	22,627	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Sale	210.00	18,008	3,781,680	4,619	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 28 '25	Sale	206.30	9,892	2,040,722	4,619	Mar 04 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 03 '25	Sale	210.45	21,250	4,472,039	6,130	Mar 04 05:00 PM
GONZALEZ RICHARD A	Officer	Mar 03 '25	Proposed Sale	210.53	6,168	1,298,550		Mar 03 05:57 PM
PERRY C SIATIS	Officer	Mar 03 '25	Proposed Sale	210.00	18,008	3,781,680		Mar 03 04:28 PM
TIMOTHY RICHMOND	Officer	Mar 03 '25	Proposed Sale	210.46	21,250	4,472,184		Mar 03 04:08 PM
GONZALEZ RICHARD A	Officer	Feb 28 '25	Proposed Sale	205.11	92,460	18,964,882		Feb 28 05:37 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Option Exercise	98.48	16,260	1,601,313	28,906	Feb 28 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Sale	203.41	18,944	3,853,372	11,496	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Option Exercise	114.36	22,210	2,539,936	66,494	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Sale	202.90	29,917	6,070,036	44,284	Feb 28 05:00 PM
PERRY C SIATIS	Officer	Feb 28 '25	Proposed Sale	206.31	9,892	2,040,790		Feb 28 04:12 PM
Buckbee Kevin K	Officer	Feb 26 '25	Proposed Sale	203.41	18,944	3,853,398		Feb 26 05:47 PM
TIMOTHY RICHMOND	Officer	Feb 26 '25	Proposed Sale	202.90	29,917	6,070,176		Feb 26 04:04 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 20 '25	Sale	197.90	5,778	1,143,453	22,381	Feb 24 05:00 PM
PERRY C SIATIS	Officer	Feb 20 '25	Proposed Sale	197.90	5,778	1,143,492		Feb 20 04:10 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Option Exercise	93.50	1,800	168,300	8,783	Dec 18 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Sale	172.24	1,800	310,032	6,983	Dec 18 05:00 PM
Buckbee Kevin K	Officer	Dec 16 '24	Proposed Sale	172.25	1,800	310,045		Dec 16 05:34 PM
Hudson Thomas J	Officer	Aug 08 '24	Proposed Sale	189.08	49,170	9,297,210		Aug 08 05:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Aug 05 '24	Sale	186.52	66,500	12,403,580	446,599	Aug 07 05:00 PM
Hudson Thomas J	Officer	Aug 07 '24	Proposed Sale	187.62	101,886	19,115,380		Aug 07 04:22 PM
GONZALEZ RICHARD A	Officer	Aug 05 '24	Proposed Sale	187.36	66,500	12,459,360		Aug 05 10:54 AM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Option Exercise	77.49	282,845	21,919,048	795,944	Jul 19 04:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Sale	175.00	282,845	49,497,875	513,099	Jul 19 04:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABBV

Abbvie Inc

Upgrade your FINVIZ experience